医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Zebrafish ppp1r21 mutant as a model for the study of primary biliary cholangitis

摘要Primary biliary cholangitis(PBC)is an autoimmune cholestatic liver disease that progresses to fibrosis and cirrhosis,resulting from the gradual destruction of intrahepatic bile ducts.Exploring genetic variants associated with PBC is essential to understand the pathogenesis of PBC.Here we identify a zebrafish balloon dog(big)mutant with intrahepatic bile duct branching defects,exhibiting several key pathological PBC-like features,including immunodominant autoantigen PDC-E2 production,cholangiocyte apoptosis,immune cell infiltration,inflammatory activation,and liver fibrosis.blg encodes the protein phosphatase 1 regulatory subunit 21(Ppp1r21),which is enriched in the liver and its peripheral tissues and plays a vital role in the early intrahepatic bile duct formation stage.Further studies show an excessive activation of the PI3K/AKT/mTOR pathway in the hepatic tissues in the mutant,while treatment with the pathway inhibitor LY294002 and rapamycin partially rescues intrahepatic bile duct branching defects and alleviates the PBC-like symptoms.These findings implicate the potential role of the Ppp1r21-mediated PI3K/AKT/mTOR pathway in the pathophysiology of PBC.

更多
广告
作者 Chaoying Wu [1] Wenfeng Zhang [1] Yiyu Luo [1] Chaoqing Cheng [1] Xinjuan Wang [1] Yan Jiang [1] Shuang Li [1] Lingfei Luo [1] Yun Yang [1] 学术成果认领
作者单位 Institute of Developmental Biology and Regenerative Medicine,Southwest University,Beibei,Chongqing 400715,China [1]
栏目名称
DOI 10.1016/j.jgg.2023.05.013
发布时间 2024-01-18(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览7
  • 下载0
遗传学报

遗传学报

2023年50卷12期

1004-1013页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷